ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,270Medicare Part D Prescriptions Filled, Including Refills

Rank: 273 out of 1107

$771K Total Retail Price of All Prescriptions

Rank: 176 out of 1107

400 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 400 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 7,246 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 428 217 S3 1 1
OMEPRAZOLE 369 247 2 4
AMLODIPINE BESYLATE 338 285 3 6
LISINOPRIL 304 185 4 2
ATORVASTATIN CALCIUM 270 197 5 13
FUROSEMIDE 268 180 6 7
SIMVASTATIN 246 182 7 5
METOPROLOL SUCCINATE 239 193 8 16
PRAVASTATIN SODIUM 210 135 9 12
LEVOTHYROXINE SODIUM 208 143 10 3
GABAPENTIN 199 111 11 9
CARVEDILOL 198 158 12 27
HYDROCHLOROTHIAZIDE 176 136 13 11
AMLODIPINE BESYLATE-BENAZEPRIL 168 125 14 77
POTASSIUM CHLORIDE 161 122 15 14
CRESTOR 161 130 15 23
GLIMEPIRIDE 140 94 17 43
CITALOPRAM HBR 139 82 18 17
METFORMIN HCL 138 81 19 8
CELEBREX 113 94 20 85
CLONIDINE HCL 112 95 21 53
SPIRIVA 110 59 22 57
RANITIDINE HCL 110 63 22 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 86 24 24
METFORMIN HCL ER 105 72 25 58
SERTRALINE HCL 105 47 25 20
NEXIUM 97 47 27 18
RAMIPRIL 96 71 28 84
METOPROLOL TARTRATE 94 70 29 10
BENAZEPRIL HCL 92 91 30 86
CLOPIDOGREL 88 57 31 28
FLUTICASONE PROPIONATE 83 33 32 38
WARFARIN SODIUM 82 58 33 15
PREDNISONE 81 39 34 40
PAROXETINE HCL 81 43 34 45
FLUOXETINE HCL 78 43 36 47
FAMOTIDINE 76 66 37 111
TAMSULOSIN HCL 74 51 38 30
PROAIR HFA 74 50 38 37
TRAMADOL HCL 72 64 40 26
ISOSORBIDE MONONITRATE ER 71 42 41 34
KLOR-CON M20 70 42 42 75
CYMBALTA 70 44 42 50
SINGULAIR 67 34 44 65
FENOFIBRATE 64 39 45 67
MELOXICAM 61 16 46 25
ALENDRONATE SODIUM 60 47 47 41
TRAZODONE HCL 60 12 47 33
AZITHROMYCIN 60 24 47 35
VENTOLIN HFA 59 34 50 97
LANTUS 58 37 51 49
LOSARTAN POTASSIUM 58 52 51 29
DONEPEZIL HCL 58 46 51 32
NAPROXEN 55 23 54 80
DOXAZOSIN MESYLATE 55 54 54 92
GLYBURIDE-METFORMIN HCL 55 42 R 54 165
PLAVIX 54 34 57 39
SYMBICORT 51 25 58 124
AMIODARONE HCL 50 40 59 199
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.